Report Highlights
The global market for fetal and neonatal monitors should grow from $4.8 billion in 2020 to $6.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025.
Report Includes
- 57 tables
- An overview of the global market for neonatal monitoring devices
- Analyses of market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Information on common neonatal anomalies and discussion on clinical significance of neonatal tests and related equipment
- Insights into government initiatives and funding and a look at the healthcare investments in developing countries
- Explanation of the major drivers and regional dynamics of the global neonatal monitoring devices market and evaluation of market size, market forecast, market share analysis and a relevant patent analysis
- Highlights of the new technological developments in neonatal monitors, and current technical issues within the industry
- Profile description of major market players including, The Cooper Companies Inc., Fujifilm Sonosite Inc., Koninklijke Philips, Medtronic PLC, Siemens Healthineers, and Spacelabs Healthcare Inc.
Report Scope
This report offers a detailed picture of the global fetal and neonatal monitor market. For the purpose of this study, the multiparameter neonatal segment encompassed the market size of devices that monitor cardiac activity, pulmonary activity or both. A few devices in this segment also monitor NIBP, temperature, regional oximetry and other parameters. The market size excludes product accessories.
The report highlights the current and future market potential of fetal and neonatal monitors and provides a detailed analysis of the competitive landscape, regulatory scenario, drivers, restraints and opportunities in the market. The report covers market projections through 2025 and detailed epidemiology analysis of fetal and neonatal mortality.
The report details the market shares of fetal and neonatal monitors, by device type. Fetal monitors are sub-divided into fetal ultrasound, electronic fetal monitors, fetal Dopplers and others (fetoscopes, IUPC and fetal scalp electrodes). Neonatal monitoring devices are further sub-segmented into multi-parameter cardiopulmonary monitors, pulse oximeters and capnography equipment and others (temperature probes, blood pressure monitors, regional oximetry monitors and hearing assessment devices).
By region, the market has been segmented into North America, Europe, Asia-Pacific, South America, the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the UK France, Spain, Italy, Japan, China, India and Australia are included. Market estimates are provided with 2019 as the base year, with forecasts for 2020-2025. The estimated values are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Hydrogen Fuel Cell: Global Markets (EGY186B)
- Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
- Single-use Technologies for Biopharmaceuticals: Global Markets (BIO099F)
- Induced Pluripotent Stem Cells: Global Markets (BIO135F)
- Commercial Amino Acids (BIO007N)
Related Reports
Fetal Monitoring, Diagnostics and Predictive Tests
The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Global Capnography Devices Market
The global capnography devices market should reach $361.7 million by 2024 from $306 million in 2019 at a compound annual growth rate (CAGR) of 3.4% for the forecast period of 2019 to 2024.
Medical Ultrasound Devices: Technologies and Global Markets
The global market for medical ultrasound devices will grow from $6.7 billion in 2018 to $7.8 billion by 2023 with a compound annual growth rate (CAGR) of 3.0% for the period of 2018-2023.
Recent Reports
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More